ClinicalTrials.gov
public full text
Public Domain
Buprenorphine vs. Opioid Dose Escalation Among Patients With Chronic Pain
This study compares buprenorphine/naloxone to opioid dose escalation among patients with poorly controlled non-cancer pain on 30-100 mg daily morphine equivalent opioid dose.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Proportional Dose of Sublingual Fentanyl Tablet Based on Daily Opioid Requirement#813630
- Efficacy of Injectable Fentanyl in Sublingual Route Versus Oral Morphine Syrup for Breakthrough Pain#979810
- Oxcarbazepine Plus Morphine in Patients With Refractory Cancer Pain#1161374
- A Comparison of Morphine and Morphine Plus Dexmedetomidine in Chronic Cancer Pain#848273
- Effect of Electroacupuncture on Opioid-induced Constipation in Patients With Cancer#1164975
Record · ID 1170960
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive